Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial
AEVI GENOMIC MEDICINE INC (GNMX)
Last aevi genomic medicine inc earnings: 11/14 08:01 am
Check Earnings Report
US:NASDAQ Investor Relations:
aevigenomics.com
Company Research
Source: PR Newswire
PHILADELPHIA, Oct. 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has reached full enrollment of Part B of its Phase 2 ASCEND clinical trial. The ASCEND trial is a genomically-guided study in pediatric and adolescent patients with Attention Deficit Hyperactivity Disorder (ADHD) assessing the safety and efficacy of AEVI-001, a novel, non-stimulant therapy. Part B of the ASCEND trial is studying pediatric and adolescent patients with ADHD without mGluR mutations. Part A of the ASCEND trial is studying a mGluR mutation positive genetic subset of pediatric and adolescent patients. Part A completed enrollment in August 2018. The accelerated enrollment in Part B will allow the Company to provide complete top line data for both Parts A and B of the ASCEND trial in January 2019. Individual and pooled analysis of Parts A and B will be conducted simultaneously, and will inform the design of the planned Phase 3 program. "We are pleas
Show less
Read more
Impact Snapshot
Event Time:
GNMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNMX alerts
High impacting AEVI GENOMIC MEDICINE INC news events
Weekly update
A roundup of the hottest topics